Balveen Kaur
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Genetics top 0.5%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
Papers in
-
- RNA Interference and Gene Delivery 20
- Viral Infectious Diseases and Gene Expression in Insects 12
- Genetics 72
- Virus-based gene therapy research 71
- Glioma Diagnosis and Treatment 14
- Co-authors
- Erwin G. Van Meir (14 shared papers)E. Antonio Chiocca (38 shared papers)Daniel J. Brat (9 shared papers)Ji Young Yoo (50 shared papers)Rolf F. Barth (4 shared papers)Jianhua Yu (24 shared papers)Michael A. Caligiuri (24 shared papers)Eric A. Severson (1 shared paper)
- Journals
- Cancer Research (13 papers)Molecular Therapy (13 papers)Clinical Cancer Research (12 papers)Neuro-Oncology (12 papers)Molecular Therapy — Oncolytics (9 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Balveen Kaur
160 papers receiving 9.1k citations
Balveen Kaur's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 1.9k
- Genetics 1.2k
- Oncology 2.9k
- Genetics 2.7k
- Immunology 1.6k
Countries citing papers authored by Balveen Kaur
This map shows the geographic impact of Balveen Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balveen Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balveen Kaur more than expected).
Fields of papers citing papers by Balveen Kaur
This network shows the impact of papers produced by Balveen Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balveen Kaur. The network helps show where Balveen Kaur may publish in the future.
Co-authors
The 25 scholars most cited alongside Balveen Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia and the hypoxia-inducible-factor pathway in glioma growth andangiogenesis Hit paper breakdown → | 2005 | 569 |
| 2 | 2004 | 386 | |
| 3 | 2009 | 359 | |
| 4 | 2006 | 300 | |
| 5 | 2015 | 296 | |
| 6 | Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. | 2002 | 268 |
| 7 | 2016 | 249 | |
| 8 | 2015 | 234 | |
| 9 | 2016 | 213 | |
| 10 | 2012 | 173 | |
| 11 | 2007 | 148 | |
| 12 | 2005 | 147 | |
| 13 | 2007 | 143 | |
| 14 | 2011 | 130 | |
| 15 | 2017 | 124 | |
| 16 | 2012 | 122 | |
| 17 | 2004 | 120 | |
| 18 | 2013 | 114 | |
| 19 | 2012 | 105 | |
| 20 | 2023 | 104 |
About Balveen Kaur
Balveen Kaur is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Epidemiology, having authored 165 papers that have together received 9.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (71 papers), CAR-T cell therapy research (30 papers), Herpesvirus Infections and Treatments (21 papers), RNA Interference and Gene Delivery (20 papers), Glioma Diagnosis and Treatment (14 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers), Cancer Research and Treatments (11 papers) and MicroRNA in disease regulation (10 papers). The work is most often cited by research in Cancer Research (1.9k citations), Genetics (1.2k citations), Oncology (2.9k citations), Genetics (2.7k citations) and Immunology (1.6k citations). Balveen Kaur has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Erwin G. Van Meir, E. Antonio Chiocca, Daniel J. Brat, Ji Young Yoo, Rolf F. Barth, Jianhua Yu, Michael A. Caligiuri, Eric A. Severson, Shannon Matheny and Fatima W. Khwaja. Their work appears in journals such as Cancer Research, Molecular Therapy, Clinical Cancer Research, Neuro-Oncology and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.